Kurs
-4,91%
Likviditet
0,60 MEUR
Kalender
| Est. tid* | ||
| 2026-10-28 | 07:00 | Kvartalsrapport 2026-Q3 |
| 2026-07-23 | 07:00 | Kvartalsrapport 2026-Q2 |
| 2026-04-28 | 07:00 | Kvartalsrapport 2026-Q1 |
| 2026-04-01 | N/A | X-dag ordinarie utdelning PIHLIS 0.53 EUR |
| 2026-03-31 | N/A | Årsstämma |
| 2026-02-12 | - | Bokslutskommuniké 2025 |
| 2025-10-31 | - | Kvartalsrapport 2025-Q3 |
| 2025-07-24 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-30 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-25 | - | X-dag ordinarie utdelning PIHLIS 0.38 EUR |
| 2025-04-24 | - | Årsstämma |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-09 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-03 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-11 | - | X-dag ordinarie utdelning PIHLIS 0.07 EUR |
| 2024-04-10 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-03 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-11 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-05 | - | X-dag ordinarie utdelning PIHLIS 0.00 EUR |
| 2023-04-04 | - | Årsstämma |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-04 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-12 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-14 | - | X-dag ordinarie utdelning PIHLIS 0.30 EUR |
| 2022-04-13 | - | Årsstämma |
| 2022-02-18 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-13 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-07 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-16 | - | X-dag ordinarie utdelning PIHLIS 0.20 EUR |
| 2021-04-15 | - | Årsstämma |
| 2021-02-19 | - | Bokslutskommuniké 2020 |
| 2020-11-04 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-14 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-08 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-16 | - | X-dag ordinarie utdelning PIHLIS 0.00 EUR |
| 2020-04-15 | - | Årsstämma |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-04-05 | - | X-dag ordinarie utdelning PIHLIS 0.10 EUR |
| 2019-04-04 | - | Årsstämma |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
| 2018-11-01 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-06 | - | X-dag ordinarie utdelning PIHLIS 0.16 EUR |
| 2018-04-05 | - | Årsstämma |
| 2018-02-13 | - | Bokslutskommuniké 2017 |
| 2017-11-09 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-11 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-05 | - | X-dag ordinarie utdelning PIHLIS 0.15 EUR |
| 2017-04-04 | - | Årsstämma |
| 2017-02-17 | - | Bokslutskommuniké 2016 |
| 2016-11-11 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-05 | - | X-dag ordinarie utdelning PIHLIS 0.00 EUR |
| 2016-04-04 | - | Årsstämma |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-12-14 | - | Extra Bolagsstämma 2015 |
| 2015-11-16 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-18 | - | Kvartalsrapport 2015-Q2 |
| 2015-06-04 | - | Kvartalsrapport 2015-Q1 |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Mid Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Pihlajalinna Plc Stock Exchange Release 12 February 2026 at 8:30 a.m. EET
Change in Pihlajalinna’s Management Team: Heikki Tarkkila will assume the role of Chief Commercial Officer
Heikki Tarkkila (Lic.Med.) has been appointed as Chief Commercial Officer of Pihlajalinna Plc and a member of the Management Team. Tarkkila has had a diverse career at McKinsey from 2018 to 2025. Most recently, as an Associate Partner, he has led McKinsey’s healthcare practice in Finland and served on McKinsey’s Nordic Healthcare leadership team. Prior to this, he co‑founded Carecode Oy and served as the company’s Director responsible for operations and sales between 2014 and 2018. Tarkkila will assume his new role on 1 March 2026.
“Our strategy centres on succeeding together with our partners – corporate clients, insurance companies and the public sector. To support this, we have strengthened our new operating model by establishing a commercial function alongside the Medical and Health Services organisations. Heikki brings us broad expertise needed in commercial thinking and growth leadership, backed by strong experience working with different service providers, insurers, investors and the pharmaceutical industry. I warmly welcome Heikki to Pihlajalinna and to our Management Team”, says Pihlajalinna’s President and CEO Tuomas Hyyryläinen.
“I have worked in healthcare both in Finland and internationally, and I will bring to Pihlajalinna my experience in developing new operating models, utilising technology and driving data‑based leadership. My background as a physician combined with business leadership helps in aligning medical and commercial priorities. I believe that together with Pihlajalinna colleagues and our partners, we can renew healthcare services in a high‑quality and impactful way to meet market needs”, says Heikki Tarkkila.
Pihlajalinna Plc
*******************************
Heikki Tarkkila
born 1988
Medical Doctor, Licentiate of Medicine
Finnish Citizen
Primary working experience
McKinsey 2018–2025
Several roles,
most recently as Associate Partner, healthcare practice
Carecode Oy, 2014–2018
Co-Founder, Head of Operation and Sales
Mehiläinen 2018–2025 (periodic)
General Practitioner, Occupational Healthcare Physician
A photo of Heikki Tarkkila is attached to this release.
Further information:
Tuula Lehto,
Executive Vice President, Communications, Marketing and Sustainability
tel. +358 40 5885 343, tuula.lehto@pihlajalinna.fi
Distribution:
Nasdaq Helsinki Ltd.
Key media
pihlajalinna.fi/en/investors
Pihlajalinna in brief
Pihlajalinna is a healthcare reformer, building effective care pathways and the most attractive corporate culture in the industry. Pihlajalinna is the most committed partner for insurance partners', corporations' and the public sector's success. The Group provides comprehensive, high-quality services through private clinics, hospitals, remote channels, work ability-supporting occupational healthcare as well as social and healthcare solutions for the public sector that deliver overall cost effectiveness. Approximately 4,500 employees and 2,300 practitioners work at Pihlajalinna. In 2025, Pihlajalinna's revenue was 652 million euros. Pihlajalinna's shares are listed on Nasdaq Helsinki Oy. Read more www.pihlajalinna.fi.